Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
The Scotts Miracle-Gro Company director reports new share award. Director David C. Evans acquired 3,271 common shares of Scotts Miracle-Gro on January 30, 2026 in a transaction reported at $0 per share, indicating a grant or award rather than an open-market purchase. After this transaction, he beneficially owns 27,724 common shares, held directly.
Scotts Miracle-Gro director Austin Scott Miller acquired additional company shares. On 01/30/2026, he acquired 3,271 common shares at a price of $0 per share, increasing his direct holdings to 4,686 common shares.
Scotts Miracle-Gro director Nick Miaritis reported receiving 3,271 common shares on January 30, 2026, at a stated price of $0 per share. After this acquisition, he beneficially owned 6,231 common shares, held directly. The transaction was reported on a Form 4 insider trading report.
Scotts Miracle-Gro director Adam Hanft reported acquiring 3,271 common shares of the company on January 30, 2026. The shares were acquired at a reported price of $0 per share, which typically indicates a stock grant or award rather than an open-market purchase. Following this transaction, Hanft directly beneficially owns 44,682 common shares of Scotts Miracle-Gro.
Scotts Miracle-Gro President and COO Nathan Eric Baxter, who is also reported as a more than 10% owner, reported new equity awards and updated holdings. On January 30, 2026, he received a stock option for 59,298 common shares at an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036.
The filing also shows a transaction coded "J" for 96.284 common shares at a price of $51.93 per share, after which Baxter directly held 66,632.3988 common shares. In addition, 36,993 common shares are reported as indirectly owned through Hagedorn Partnership, L.P., where he is a general partner and may be deemed to have a proportionate beneficial interest under the SEC’s Rule 16a-1(a)(1).
Scotts Miracle-Gro director Peter E. Shumlin reported stock-based awards and conversions. On 01/30/2026, he acquired 4,049 common shares at $0, bringing his direct holdings to 30,328 shares. On 02/02/2026, 182 dividend equivalent rights were converted at $0 into 182 common shares, increasing his direct ownership to 30,510 shares.
The 182-share conversion came from dividend equivalent rights tied to a grant of 1,398 restricted stock units awarded on February 3, 2023, which vest on February 2, 2026. After this transaction, 1,028 dividend equivalent rights remain outstanding.
Scotts Miracle-Gro EVP, CFO & CAO Mark J. Scheiwer reported new equity awards and updated share holdings. On January 30, 2026, he received 29,649 stock options with an exercise price of $64.22 per common share, all held directly. The same day, he acquired 2.888 common shares at $51.93 each, bringing his directly held common shares to 15,288.741. He also reported indirect ownership of 493.482 common shares through a 401(k) plan.
Scotts Miracle-Gro director Stephen L. Johnson reported two stock awards. On January 30, 2026, he acquired 112 common shares of SCOTTS MIRACLE-GRO at $64.22 per share, bringing this holding to 27,520 shares.
On the same date, Johnson also received 3,271 common shares at a price of $0, described as Deferred Stock Units issued in lieu of a $7,188 retainer. After this grant, his directly held common shares increased to 30,791.
Scotts Miracle-Gro Chairman & CEO James Hagedorn, also a director and more than 10% owner, reported equity-related changes in his holdings. On January 30, 2026, he received a stock option grant for 142,315 common shares with an exercise price of $64.22 per share, expiring between January 30, 2029 and January 30, 2036. He also acquired 38.513 common shares at $51.93 per share, bringing his directly held common shares to 104,112.9728. In addition, he reported indirect holdings of 31,533.64 common shares through a 401(k) plan and 997,910 common shares through Hagedorn Partnership, L.P., reflecting his proportionate and family pecuniary interests.
Scotts Miracle-Gro director Brian E. Sandoval reported routine equity awards and vesting activity. On 01/30/2026, he acquired 448 common shares at $64.22 as deferred stock units issued in lieu of a $28,750 director retainer, and 3,271 additional common shares at $0.
On 02/02/2026, 182 restricted stock units, including dividend equivalent rights from a grant of 1,398 units awarded on February 3, 2023, converted into 182 common shares on a one-for-one basis. After these transactions, he directly owned 18,387 common shares and 972 dividend equivalent rights. The filing reflects compensation and vesting rather than an open‑market sale.